GlassScriptPhysician profile
Michael J Kelley
NPI 1548376494
$574.82
in general payments reported to CMS, 2019-2025
14 companies · $30.93 in 2025
The $30.93 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8.52 · 2021: $54.05 · 2022: $167 · 2023: $76.97 · 2024: $238 · 2025: $30.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $200.64 | 2021-2024 | Puraply |
| Angiodynamics, INC. | $179.98 | 2024 | Auryon Laser System 100-120 Vac |
| Convatec INC. | $22.45 | 2024 | |
| Grt US Holding, INC. | $20.99 | 2021 | |
| Medtronic, INC. | $18.43 | 2024 | Intellis Adaptivestim |
| Orthofix Medical, INC. | $17.96 | 2019-2021 | |
| Abbvie INC. | $17.31 | 2022 | |
| Cashflow Solutions, LLC | $16.95 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Lifenet Health | $15.55 | 2023 | |
| Paratek Pharmaceuticals, INC. | $15.00 | 2022 | |
| Kci USA, INC. | $14.95 | 2023 | V.A.C. Dermatac, Activ.A.C., Kerramax Care |
| Stryker Corporation | $13.98 | 2025 | Actishield |
| Zimmer Biomet Holdings, INC. | $11.89 | 2022 | |
| Heron Therapeutics, INC. | $8.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.